PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS

CMV infection is a major problem in kidney transplantation patients. Valcyte, Cimevene are the first line thera- py of CMV infection. This pharmacoeconomic analysis shown economic benefits of Valcyte prophylaxis tactic compare preemptive strategy.

Bibliographic Details
Main Authors: V. V. Ryazhenov, S. G. Gorokhova
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2011-06-01
Series:Vestnik Transplantologii i Iskusstvennyh Organov
Subjects:
Online Access:https://journal.transpl.ru/vtio/article/view/411
_version_ 1797872088835424256
author V. V. Ryazhenov
S. G. Gorokhova
author_facet V. V. Ryazhenov
S. G. Gorokhova
author_sort V. V. Ryazhenov
collection DOAJ
description CMV infection is a major problem in kidney transplantation patients. Valcyte, Cimevene are the first line thera- py of CMV infection. This pharmacoeconomic analysis shown economic benefits of Valcyte prophylaxis tactic compare preemptive strategy.
first_indexed 2024-04-10T00:53:16Z
format Article
id doaj.art-aa02b547067446aa921e2e6d942db6ae
institution Directory Open Access Journal
issn 1995-1191
language Russian
last_indexed 2024-04-10T00:53:16Z
publishDate 2011-06-01
publisher Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
record_format Article
series Vestnik Transplantologii i Iskusstvennyh Organov
spelling doaj.art-aa02b547067446aa921e2e6d942db6ae2023-03-13T10:37:21ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovVestnik Transplantologii i Iskusstvennyh Organov1995-11912011-06-01133202510.15825/1995-1191-2011-3-20-25354PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTSV. V. Ryazhenov0S. G. Gorokhova1I.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityCMV infection is a major problem in kidney transplantation patients. Valcyte, Cimevene are the first line thera- py of CMV infection. This pharmacoeconomic analysis shown economic benefits of Valcyte prophylaxis tactic compare preemptive strategy.https://journal.transpl.ru/vtio/article/view/411kidney transplantationcmv infectionbudget impact analysiseconomic rational indicator of previous periods cost.
spellingShingle V. V. Ryazhenov
S. G. Gorokhova
PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
Vestnik Transplantologii i Iskusstvennyh Organov
kidney transplantation
cmv infection
budget impact analysis
economic rational indicator of previous periods cost.
title PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
title_full PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
title_fullStr PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
title_full_unstemmed PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
title_short PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
title_sort pharmacoeconomic benefits of cytomegalovirus infection prophylactic strategy for renal transplant recipients
topic kidney transplantation
cmv infection
budget impact analysis
economic rational indicator of previous periods cost.
url https://journal.transpl.ru/vtio/article/view/411
work_keys_str_mv AT vvryazhenov pharmacoeconomicbenefitsofcytomegalovirusinfectionprophylacticstrategyforrenaltransplantrecipients
AT sggorokhova pharmacoeconomicbenefitsofcytomegalovirusinfectionprophylacticstrategyforrenaltransplantrecipients